“Possibly life-threatening (SAEs) in organ syste
Post# of 154440
(Total Views: 875)
Posted On: 11/16/2020 1:26:46 AM
“Possibly life-threatening (SAEs) in organ systems THAT ARE CONFIRMED INDICATIONS IN CV19 are.”
So you admit that the side effects (including SAEs) are possible and not likely to occur in every patient? I appreciate that. Steven Johnson’s has been reported as a side effect of ibuprofen but that doesn’t stop it from being sold over the counter.
“The amount of liability involved with throwing random medications at patients is immense..”
You obviously have not prescribed medications before. Medications aren’t “thrown randomly” at patients and instead, like I said before, are carefully chosen. More than just occasionally the best drug for a certain diagnosis has side effects which requires different levels of monitoring in the hospital or on an outpatient level.
“Any ****head dismissing the possibility of exacerbating organ damage or death as a result is playing God, and falling woefully short.”
Again, those who’ve prescribed medications always make a cost benefit analysis when choosing a medication. And again, even patients with already existing organ damage need mediation to prevent them from circling the drain, even if that results in other side effects.
“there have been several rabid cheerleaders for Mara”
There are few researchers and/or doctors with the credentials and expertise of Dr. BP. His choice to study the use of maraviroc in LHs was not rabid nor the act of a cheerleader. He doesn’t have access to leronlimab so he chose the next available CCR5 MAB. Pretty simple.
Also, maraviroc has side effects but isn’t as damaging as CYDY investors make it out to be. There were only 2 cases of acute hepatocellular injury reported in the trials. Additionally, an NIH study found that, “therapy with maraviroc was associated with alanine aminotransferase (ALT) elevations in up to 10% of patients, but elevations above 5 times normal are less common. Furthermore, rates of ALT elevations with maraviroc were similar to rates in comparator groups receiving similar background optimized antiretroviral therapy [2.6% vs 3.4% above 5 times ULN in one study and 3.9% vs 4.0% in a second]. The serum aminotransferase abnormalities that occur during maraviroc therapy are usually mild and self-limited, not requiring dose modification or discontinuation.“ That’s not my opinion, but facts published by the NIH.
You know what else cause elevations in ALT and AST in up to 15% of patients? You guessed it, ibuprofen.
“That might all be a bunch of gibberish to you, but it sounds like a list of CV19 indications to anyone without an ulterior agenda.”
No ulterior agendas here. I’ve, been a CYDY investor since 2015 and I’m very happy with my returns and current position.
So you admit that the side effects (including SAEs) are possible and not likely to occur in every patient? I appreciate that. Steven Johnson’s has been reported as a side effect of ibuprofen but that doesn’t stop it from being sold over the counter.
“The amount of liability involved with throwing random medications at patients is immense..”
You obviously have not prescribed medications before. Medications aren’t “thrown randomly” at patients and instead, like I said before, are carefully chosen. More than just occasionally the best drug for a certain diagnosis has side effects which requires different levels of monitoring in the hospital or on an outpatient level.
“Any ****head dismissing the possibility of exacerbating organ damage or death as a result is playing God, and falling woefully short.”
Again, those who’ve prescribed medications always make a cost benefit analysis when choosing a medication. And again, even patients with already existing organ damage need mediation to prevent them from circling the drain, even if that results in other side effects.
“there have been several rabid cheerleaders for Mara”
There are few researchers and/or doctors with the credentials and expertise of Dr. BP. His choice to study the use of maraviroc in LHs was not rabid nor the act of a cheerleader. He doesn’t have access to leronlimab so he chose the next available CCR5 MAB. Pretty simple.
Also, maraviroc has side effects but isn’t as damaging as CYDY investors make it out to be. There were only 2 cases of acute hepatocellular injury reported in the trials. Additionally, an NIH study found that, “therapy with maraviroc was associated with alanine aminotransferase (ALT) elevations in up to 10% of patients, but elevations above 5 times normal are less common. Furthermore, rates of ALT elevations with maraviroc were similar to rates in comparator groups receiving similar background optimized antiretroviral therapy [2.6% vs 3.4% above 5 times ULN in one study and 3.9% vs 4.0% in a second]. The serum aminotransferase abnormalities that occur during maraviroc therapy are usually mild and self-limited, not requiring dose modification or discontinuation.“ That’s not my opinion, but facts published by the NIH.
You know what else cause elevations in ALT and AST in up to 15% of patients? You guessed it, ibuprofen.
“That might all be a bunch of gibberish to you, but it sounds like a list of CV19 indications to anyone without an ulterior agenda.”
No ulterior agendas here. I’ve, been a CYDY investor since 2015 and I’m very happy with my returns and current position.
(7)
(1)